Psychosomatic - psychotherapeutic treatment of stress-related disorders impacts the sphingolipid metabolism towards increased sphingosine and sphingosine-1-phosphate levels

Psychosomatic - psychotherapeutic treatment was associated with a reduction in specific ceramide ratios and an increase in sphingosine and S1P levels potentially resulting from increased activity of sphingolipid metabolizing enzymes. Stress-induced mental disorders might be associated with disturbed sphingolipid levels that seem to be balanced during psychosomatic treatment. This study offers a further piece of evidence that the sphingolipid metabolism could be involved in the pathophysiology of stress-induced disorders, and its analysis could be helpful for treatment monitoring.

Authors

Institutions

Publication Details

Journal
European Archives of Psychiatry and Clinical Neuroscience
Published
2025-03-05
DOI
https://doi.org/10.1007/s00406-025-01985-2
Citations
4
Primary Topic
Sphingolipid Metabolism and Signaling
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychosomatic - psychotherapeutic treatment of stress-related disorders impacts the sphingolipid metabolism towards increased sphingosine and sphingosine-1-phosphate levels

Burkhard Kleuser, Franziska Werner, Caterina Schug, Eva Schäflein et al.
4 citations
European Archives of Psychiatry and Clinical Neuroscience
Sphingolipid Metabolism and Signaling
3.22
article

Psychosomatic - psychotherapeutic treatment of stress-related disorders impacts the sphingolipid metabolism towards increased sphingosine and sphingosine-1-phosphate levels

Burkhard Kleuser, Franziska Werner, Caterina Schug, Eva Schäflein, Fabian Schumacher, Werner Adler, Cosima Rhein, Eva Morawa, Johannes Kornhuber, Yeşim Erim, Christiane Mühle
article en
4 citations

Abstract

Psychosomatic - psychotherapeutic treatment was associated with a reduction in specific ceramide ratios and an increase in sphingosine and S1P levels potentially resulting from increased activity of sphingolipid metabolizing enzymes. Stress-induced mental disorders might be associated with disturbed sphingolipid levels that seem to be balanced during psychosomatic treatment. This study offers a further piece of evidence that the sphingolipid metabolism could be involved in the pathophysiology of stress-induced disorders, and its analysis could be helpful for treatment monitoring.

European Archives of Psychiatry and Clinical NeuroscienceVol. 275(7)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Klinik und Poliklinik für Psychotherapie und Psychosomatik (DE), Freie Universität Berlin (DE), Technische Universität Dresden (DE)
Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen
Openalex Percentile: Top 9%
Sphingolipid Metabolism and Signaling
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.